The cholesterol pathway of Trypanosoma congolense could be a target for triphenyltinsalicylate and triphenylsiliconsalicylate inhibition

The organometallic compounds triphenyltinsalicylate (TPTS) and triphenylsiliconsalicylate (TPSS) were found to be trypanocidal against culture forms of Trypanosoma congolense. Both compounds at 0.4–5 µmol ml−1 completely killed the parasites in vitro within 3-8 min after incubation. A dosage of 1.5 µmol ml−1 TPTS killed at least 50% of the parasite population, which was preceded by a cluster effect as observed under phase contrast microscopy. Also, 3.5 µg ml−1 of TPSS was required to kill 50% of the T. congolense cells. At a low dosage of 2–10 µg ml−1, it was feasible to monitor the effect and mode of action of the organometallic compounds. There was a 50% reduction in the amount of synthesized cholesterols in the presence of 6 µg ml−1 and 10 µg ml−1 of TPTS and TPSS respectively. TPTS and TPSS also non-competitively inhibited pyrophosphatase from lysed T. congolense with Ki values of 3.6 µM and 8.5 µM respectively. In the in vivo experiments, TPTS cured T. congolense infected mice at a dosage of 2–10 mg kg day−1 for 4 days. TPSS was, however, completely inactive in vivo. The use of organometallic compounds in the design of trypanocides is discussed. Copyright © 2002 John Wiley & Sons, Ltd.

[1]  S. Fricker,et al.  The in vitro antitumour profile of some 1,2-diaminocyclohexane organotin complexes. , 2001, Journal of inorganic biochemistry.

[2]  A. Nok,et al.  Trypanocidal activity of organotin chlorides on Trypanosoma brucei-infected mice. , 2000, Parasite.

[3]  S. Ado,et al.  Triphenyltin Salicylate-Antimicrobial Effect and Resistance - The Pyrophosphatase Connection , 2000, Journal of enzyme inhibition.

[4]  Silverman,et al.  Selective Inhibition of Monoamine Oxidase B by Aminoethyl Substituted Benzyl Ethers. , 1999, Journal of enzyme inhibition.

[5]  A. Pain,et al.  Characterization of Organotin-Resistant Bacteria from Boston Harbor Sediments , 1998, Archives of environmental contamination and toxicology.

[6]  I. Coppens,et al.  Exogenous and endogenous sources of sterols in the culture-adapted procyclic trypomastigotes of Trypanosoma brucei. , 1995, Molecular and biochemical parasitology.

[7]  A. Nok,et al.  Phospholipase A2 from Trypanosoma congolense: Characterization and haematological properties , 1993, Cell biochemistry and function.

[8]  A. Bitonti,et al.  Cure of murine Trypanosoma brucei rhodesiense infections with an S-adenosylmethionine decarboxylase inhibitor , 1992, Antimicrobial Agents and Chemotherapy.

[9]  M. Millar,et al.  Bactericidal activity of antimicrobial agents against slowly growing Helicobacter pylori , 1992, Antimicrobial Agents and Chemotherapy.

[10]  K. Esievo,et al.  Trypanocidal Activity of an Organotin Compound (Tri-n-Butyltin Oxide) toward Trypanosoma brucei. , 1992 .

[11]  A. Samad,et al.  The acquisition of lipids AfrAfrican trypanosomes , 1989 .

[12]  J. Gray,et al.  Structural effects on the antitumour activity of a series of di(4‐substituted phenyl)tin dichloride complexes with nitrogen‐donor ligands , 1989 .

[13]  I. Coppens,et al.  Receptors for the host low density lipoproteins on the hemoflagellate Trypanosoma brucei: purification and involvement in the growth of the parasite. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[14]  K. Vickerman Developmental cycles and biology of pathogenic trypanosomes. , 1985, British medical bulletin.

[15]  W. Gutteridge Existing chemotherapy and its limitations. , 1985, British medical bulletin.

[16]  E. M. Crook 1st international meeting on cell biochemistry and function , 1983 .

[17]  M. Turner Biochemistry of the variant surface glycoproteins of salivarian trypanosomes. , 1982, Advances in parasitology.

[18]  R. Searcy,et al.  Rapid ultramicro estimation of serum total cholesterol. , 1960, Journal of lipid research.